3 Largest Private Hospital Network, Pune and Indore Hospital Operator and Premium Multi-Specialty Chain Stocks With a Strong Future Roadmap: Apollo Hospitals Enterprise, Jupiter Life Line Hospitals and Max Healthcare Institute
- October 26, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Apollo Hospitals Enterprise, Jupiter Life Line Hospitals and Max Healthcare Institute: ROE of 11.4% to 20.5% and FY22 to FY26 revenue CAGR of 14.6% to 20.4%. Prices as of 23 Oct 2026.
Quick Answer
The three hospital chain and city care stocks to watch are Apollo Hospitals Enterprise, Jupiter Life Line Hospitals and Max Healthcare Institute. Their return on equity ranges from 11.4% to 20.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.6% to 20.4%. Apollo Hospitals Enterprise has the highest return on equity at 20.5%, while Max Healthcare Institute has the fastest revenue growth at 20.4% a year. Prices are based on the 23 October 2026 close, and this article is educational, not investment advice.
Hospital chain and city care stocks offer a focused view of a sector where demand keeps widening. Apollo Hospitals Enterprise, Jupiter Life Line Hospitals and Max Healthcare Institute cover a largest private hospital network, a Pune and Indore hospital operator and a premium multi-specialty chain.
This list covers three hospital chain and city care stocks with complete current figures: Apollo Hospitals Enterprise, Jupiter Life Line Hospitals and Max Healthcare Institute. Every figure comes from the latest reported financials and the 23 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Hospital Chain and City Care Stocks?
Hospital chain and city care stocks are listed healthcare companies that run hospitals in large and mid-sized cities. Their earnings depend on bed capacity, patient volumes, specialty mix and pricing.
Hospital Chain and City Care Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | 7,730 | 110,757 | 51.0 | 59.6 | 20.5 | 0.90 |
| Jupiter Life Line Hospitals | 244 | 8,007 | 42.6 | 58.4 | 11.4 | 0.41 |
| Max Healthcare Institute | 815 | 80,717 | 55.4 | 59.6 | 13.4 | 0.32 |
On valuation, all three trade at a P/E below their industry P/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing hospital chain and city care stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Hospital Chain and City Care Stocks Have a Strong Roadmap in India?
Hospital chain and city care stocks have a strong roadmap in India because rising insurance cover, medical travel and demand for advanced treatment keep lifting admissions at organised hospital chains.
- Bed additions. New capacity adds patient volumes.
- Specialty care. Advanced treatments raise revenue per patient.
- Insurance cover. More households can afford private care.
Why Apollo Hospitals Enterprise Features Among These Hospital Chain and City Care Stocks
Among the hospital chain and city care stocks on this list, Apollo Hospitals Enterprise is India’s largest private healthcare group, running a network of hospitals along with a pharmacy chain, diagnostics, primary care clinics and a digital health platform.
The company has a return on equity of 20.5%, a debt to equity ratio of 0.90 and a market capitalisation of Rs 110,757 crore. The stock trades at a P/E of 51.0, below the industry P/E of 59.6.
Revenue rose from Rs 14,741 crore in FY22 to Rs 25,420 crore in FY26, a compound annual growth rate of 14.6%. Net profit grew from Rs 1,101 crore in FY22 to Rs 2,003 crore in FY26, which works out to a compound annual growth rate of 16.1%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 7,092 crore, while net profit rose 38.4% to Rs 610 crore.
Roadmap: The company is adding hospital beds in proven cities while growing its pharmacy and digital businesses, which broaden its reach beyond inpatient care. A strong brand in complex treatment and a wide patient base support steady occupancy.
What to watch: Track bed additions and occupancy and the growth of the pharmacy and digital health businesses.
Why Jupiter Life Line Hospitals Features Among These Hospital Chain and City Care Stocks
Among the national hospital network shares on this list, Jupiter Life Line Hospitals runs multi-speciality hospitals in Pune, Thane and Indore, with strong services in maternity, child care, critical care and advanced surgery.
Revenue rose from Rs 737 crore in FY22 to Rs 1,542 crore in FY26, a compound annual growth rate of 20.3%. Net profit grew from Rs 51.1 crore in FY22 to Rs 194 crore in FY26, which works out to a compound annual growth rate of 39.6%.
The company has a return on equity of 11.4%, a debt to equity ratio of 0.41 and a market capitalisation of Rs 8,007 crore. The stock trades at a P/E of 42.6, below the industry P/E of 58.4.
Roadmap: The company is adding beds and expanding to new locations while growing specialist services. Rising demand for quality private care in its cities supports occupancy.
What to watch: Follow bed additions, occupancy levels and revenue per occupied bed.
Why Max Healthcare Institute Features Among These Hospital Chain and City Care Stocks
Among the three companies on this list, Max Healthcare Institute runs a large network of multi-specialty hospitals concentrated in Delhi NCR, Punjab, Uttarakhand and Maharashtra, with a strong presence in oncology, cardiac sciences, neurosciences and orthopaedics.
In the June 2026 quarter, revenue grew 16.6% year on year to Rs 2,407 crore, while net profit rose 4.9% to Rs 323 crore. Revenue rose from Rs 4,059 crore in FY22 to Rs 8,536 crore in FY26, a compound annual growth rate of 20.4%.
Net profit grew from Rs 605 crore in FY22 to Rs 1,442 crore in FY26, which works out to a compound annual growth rate of 24.3%. The company has a return on equity of 13.4%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 80,717 crore. The stock trades at a P/E of 55.4, below the industry P/E of 59.6.
Roadmap: The roadmap rests on adding beds through brownfield expansion at existing campuses and through new hospitals in cities where the group already has referral strength. Higher bed occupancy and a richer case mix lift revenue per occupied bed, which is the number hospital analysts follow most closely.
What to watch: Track how quickly new beds reach stable occupancy and whether average revenue per occupied bed keeps rising.
Apollo Hospitals Enterprise vs Jupiter Life Line Hospitals vs Max Healthcare Institute on Key Financials
The table below sets the three hospital chain and city care stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | 14,741 | 25,420 | 14.6% | 2,003 | 7.9% |
| Jupiter Life Line Hospitals | 737 | 1,542 | 20.3% | 194 | 12.6% |
| Max Healthcare Institute | 4,059 | 8,536 | 20.4% | 1,442 | 16.9% |
Apollo Hospitals Enterprise posts the highest return on equity in this group at 20.5%. Apollo Hospitals Enterprise has the largest FY26 revenue at Rs 25,420 crore, and Max Healthcare Institute shows the fastest revenue growth with a 20.4% compound annual rate. A useful habit with hospital chain and city care stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Hospital Chain and City Care Stocks
Every theme carries risks that deserve a check before any decision. For these hospital chain and city care stocks, the main points are: Long-term national hospital network shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Capacity timing. New beds take time to mature.
- Pricing. Health care pricing rules can affect revenue.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter hospital chain and city care stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Hospital Chain and City Care Stocks
Hospital chain and city care stocks reward patient research into demand, execution and financial strength. Apollo Hospitals Enterprise, Jupiter Life Line Hospitals and Max Healthcare Institute each have a clear plan to expand. Based on the 23 October 2026 close, Apollo Hospitals Enterprise trades at Rs 7,730, Jupiter Life Line Hospitals at Rs 244 and Max Healthcare Institute at Rs 815. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these hospital chain and city care stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track hospital chain and city care stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are hospital chain and city care stocks?
Ans. Hospital chain and city care stocks are listed healthcare companies that run hospitals in large and mid-sized cities. Their earnings depend on bed capacity, patient volumes, specialty mix and pricing. This list looks at three of them, Apollo Hospitals Enterprise, Jupiter Life Line Hospitals and Max Healthcare Institute, using reported FY22 to FY26 financials and the 23 October 2026 closing prices.
Which hospital chain and city care stocks are covered in this list?
Ans. This list covers Apollo Hospitals Enterprise, Jupiter Life Line Hospitals and Max Healthcare Institute. Based on the 23 October 2026 close, Apollo Hospitals Enterprise traded at Rs 7,730, Jupiter Life Line Hospitals at Rs 244 and Max Healthcare Institute at Rs 815. Their return on equity ranges from 11.4% to 20.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.6% to 20.4%.
Why do hospital chain and city care stocks have a strong future roadmap in India?
Ans. Hospital chain and city care stocks have a strong roadmap in India because rising insurance cover, medical travel and demand for advanced treatment keep lifting admissions at organised hospital chains. The main drivers are as follows. Bed additions. New capacity adds patient volumes. Specialty care. Advanced treatments raise revenue per patient. Insurance cover. More households can afford private care. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Apollo Hospitals Enterprise performed financially?
Ans. Revenue rose from Rs 14,741 crore in FY22 to Rs 25,420 crore in FY26, a compound annual growth rate of 14.6%. Net profit grew from Rs 1,101 crore in FY22 to Rs 2,003 crore in FY26, which works out to a compound annual growth rate of 16.1%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 7,092 crore, while net profit rose 38.4% to Rs 610 crore. The company has a return on equity of 20.5%, a debt to equity ratio of 0.90 and a market capitalisation of Rs 110,757 crore. The stock trades at a P/E of 51.0, below the industry P/E of 59.6. Looking ahead, the company is adding hospital beds in proven cities while growing its pharmacy and digital businesses, which broaden its reach beyond inpatient care. A strong brand in complex treatment and a wide patient base support steady occupancy.
How has Jupiter Life Line Hospitals performed financially?
Ans. Revenue rose from Rs 737 crore in FY22 to Rs 1,542 crore in FY26, a compound annual growth rate of 20.3%. Net profit grew from Rs 51.1 crore in FY22 to Rs 194 crore in FY26, which works out to a compound annual growth rate of 39.6%. The company has a return on equity of 11.4%, a debt to equity ratio of 0.41 and a market capitalisation of Rs 8,007 crore. The stock trades at a P/E of 42.6, below the industry P/E of 58.4. Looking ahead, the company is adding beds and expanding to new locations while growing specialist services. Rising demand for quality private care in its cities supports occupancy.
How has Max Healthcare Institute performed financially?
Ans. Revenue rose from Rs 4,059 crore in FY22 to Rs 8,536 crore in FY26, a compound annual growth rate of 20.4%. Net profit grew from Rs 605 crore in FY22 to Rs 1,442 crore in FY26, which works out to a compound annual growth rate of 24.3%. In the June 2026 quarter, revenue grew 16.6% year on year to Rs 2,407 crore, while net profit rose 4.9% to Rs 323 crore. The company has a return on equity of 13.4%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 80,717 crore. The stock trades at a P/E of 55.4, below the industry P/E of 59.6. Looking ahead, the roadmap rests on adding beds through brownfield expansion at existing campuses and through new hospitals in cities where the group already has referral strength. Higher bed occupancy and a richer case mix lift revenue per occupied bed, which is the number hospital analysts follow most closely.
What risks should investors check before buying hospital chain and city care stocks?
Ans. Investors should check a few risks before buying hospital chain and city care stocks. Capacity timing. New beds take time to mature. Pricing. Health care pricing rules can affect revenue. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of hospital chain and city care stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 23 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
